Forian Inc.FORAEarnings & Financial Report
Forian Inc is a specialized healthcare technology and data analytics firm offering SaaS-based real-world evidence solutions, clinical decision support tools, and operational optimization services. It serves biopharmaceutical companies, healthcare providers, and life sciences stakeholders to improve patient outcomes, accelerate research, and boost care delivery efficiency.
FORA Q4 FY2025 Key Financial Metrics
Revenue
$8.0M
Gross Profit
$3.9M
Operating Profit
$-1.9M
Net Profit
$-1.8M
Gross Margin
49.2%
Operating Margin
-24.4%
Net Margin
-22.9%
YoY Growth
37.0%
EPS
$-0.06
Forian Inc. Q4 FY2025 Financial Summary
Forian Inc. reported revenue of $8.0M (up 37.0% YoY) for Q4 FY2025, with a net profit of $-1.8M (down 1012.2% YoY) (-22.9% margin). Cost of goods sold was $4.0M, operating expenses totaled $5.9M.
Key Financial Metrics
| Total Revenue | $8.0M |
|---|---|
| Net Profit | $-1.8M |
| Gross Margin | 49.2% |
| Operating Margin | -24.4% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Forian Inc. Q4 FY2025 revenue of $8.0M breaks down across 2 segments, led by Financial Services Revenues at $7.3M (91.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Financial Services Revenues | $7.3M | 91.6% |
| Other | $669.0K | 8.4% |
Forian Inc. Revenue by Segment — Quarterly Trend
Forian Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Financial Services Revenues and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Financial Services Revenues | $7.3M | — | — | — |
| Other | $669.0K | $261.5K | — | — |
Forian Inc. Annual Revenue by Year
Forian Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $30.3M).
Forian Inc. Quarterly Revenue & Net Profit History
Forian Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $8.0M | +37.0% | $-1.8M | -22.9% |
| Q3 FY2025 | $7.8M | +65.6% | $-151.2K | -1.9% |
| Q2 FY2025 | $7.5M | +56.5% | $224.8K | 3.0% |
| Q1 FY2025 | $7.1M | +44.7% | $-1.1M | -16.0% |
| Q4 FY2024 | $5.8M | +5.5% | $199.7K | 3.4% |
| Q3 FY2024 | $4.7M | -15.3% | $-204.9K | -4.4% |
| Q2 FY2024 | $4.8M | -6.3% | $-2.6M | -53.4% |
| Q1 FY2024 | $4.9M | -3.9% | $-1.2M | -24.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9M | $4.8M | $4.7M | $5.8M | $7.1M | $7.5M | $7.8M | $8.0M |
| YoY Growth | -3.9% | -6.3% | -15.3% | 5.5% | 44.7% | 56.5% | 65.6% | 37.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $57.5M | $58.4M | $57.5M | $47.2M | $48.6M | $48.5M | $41.3M | $44.1M |
| Liabilities | $31.0M | $32.7M | $30.6M | $17.1M | $18.6M | $17.5M | $10.2M | $14.4M |
| Equity | $28.1M | $27.2M | $28.4M | $30.1M | $30.0M | $30.9M | $31.1M | $29.8M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.2M | $-23110 | $764096 | $1.7M | $448180 | $-344531 | $-439666 | $3.2M |